Clearing the haze: the complexities and challenges of research on state marijuana laws

Annals of the New York Academy of Sciences

Volumn 1394, Issue 1, 2017, Pages 55-73

  Choo, Esther K ^a   Emery, Sherry L ^b  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^b Health Media Collaboratory   (United States)

Author keywords

cannabis; law; legislation; marijuana; policy

Indexed keywords

CANNABIS; MEDICAL CANNABIS; RECREATIONAL DRUG; STREET DRUG;

COMMERCIAL PHENOMENA; CRIME; HUMAN; LAW; MEASUREMENT ACCURACY; MEDICAL RESEARCH; META ANALYSIS (TOPIC); OUTCOME ASSESSMENT; QUASI EXPERIMENTAL STUDY; RECREATION; REVIEW; STUDY DESIGN; SYSTEMATIC REVIEW (TOPIC); UNITED STATES; DRUG LEGISLATION; LEGISLATION AND JURISPRUDENCE; RESEARCH; TRENDS;

CANNABIS; HUMANS; LEGISLATION, DRUG; MEDICAL MARIJUANA; RESEARCH; STREET DRUGS; UNITED STATES;

EID: 85006459113     PISSN: 00778923     EISSN: 17496632     Source Type: Journal    
DOI: 10.1111/nyas.13093     Document Type: Review

References (134)

1. Drug Enforcement Administration: Drug Scheduling. Accessed February 1, 2016. http://www.dea.gov/druginfo/ds.shtml.
2. Hawken, A., J. Caulkins, B. Kilmer & M. Kleiman. 2013. Quasi-legal cannabis in Colorado and Washington: local and national implications. Addiction 108: 837–838.
3. Lorber, L. 2005. Gonzales v Raich: the US Supreme Court's consideration captured the public policy debate about the medical use of marijuana. Gend. Med. 2: 124–130.
4. California Department of Public Health. 1996. Medical marijuana program: Compassionate Use Act. Proposition 215. Accessed March 28, 2016. https://www.cdph.ca.gov/programs/MMP/Pages/CompassionateUseact.aspx.
5. Pew Research Center. 2015. In debate over legalizing marijuana, disagreement over drug's dangers. Washington, DC: Pew Research Center. Accessed February 9, 2016. http://www.people-press.org/2015/04/14/in-debate-over-legalizing-marijuana-disagreement-over-drugs-dangers/.
6. Berg, C.J., E. Stratton, G.L. Schauer, et al. 2015. Perceived harm, addictiveness, and social acceptability of tobacco products and marijuana among young adults: marijuana, hookah, and electronic cigarettes win. Subst. Use Misuse 50: 79–89.
7. Macdonald, S., P. Erickson, S. Wells, et al. 2008. Predicting violence among cocaine, cannabis, and alcohol treatment clients. Addict. Behav. 33: 201–220.
8. Gilbert, L., N. El-Bassel, M. Chang, et al. 2012. Substance use and partner violence among urban women seeking emergency care. Psychol. Addict. Behav. 26: 226–235.
9. Korcha, R.A., C.J. Cherpitel, J. Witbrodt, et al. 2014. Violence-related injury and gender: the role of alcohol and alcohol combined with illicit drugs. Drug Alcohol Rev. 33: 43–50.
10. Winstock, A. The Global Drug Survey 2015 Findings Accessed January 25, 2016. http://www.globaldrugsurvey.com/the-global-drug-survey-2015-findings/.
11. Centers for Disease Control and Prevention. 2013. 1997–2009 Youth Risk Behavior Survey. Accessed February 3, 2016. www.cdc.gov/yrbss.
12. United Nations Office on Drugs and Crime. 2012. World drug report. Accessed January 10, 2016. http://www.unodc.org/documents/data-and-analysis/WDR2012/WDR_2012_web_small.pdf.
13. Nutt, D., L.A. King, W. Saulsbury & C. Blakemore. 2007. Development of a rational scale to assess the harm of drugs of potential misuse. Lancet 369: 1047–1053.
14. Whiting, P.F., R.F. Wolff, S. Deshpande, et al. 2015. Cannabinoids for medical use: a systematic review and meta-analysis. JAMA 313: 2456.
15. Di Forti, M., A. Marconi, E. Carra, et al. 2015. Proportion of patients in south London with first-episode psychosis attributable to use of high potency cannabis: a case–control study. Lancet Psychiatry 2: 233–238.
16. Kelley, M.E., C.R. Wan, B. Broussard, et al. 2016. Marijuana use in the immediate 5-year premorbid period is associated with increased risk of onset of schizophrenia and related psychotic disorders. Schizophr. Res. 171: 62–67.
17. Schweinsburg, A.D., S.A. Brown & S.F. Tapert. 2008. The influence of marijuana use on neurocognitive functioning in adolescents. Curr. Drug Abuse Rev. 1: 99–111.
18. Schweinsburg, A.D., B.J. Nagel, B.C. Schweinsburg, et al. 2008. Abstinent adolescent marijuana users show altered fMRI response during spatial working memory. Psychiatry Res. 163: 40–51.
19. Centers for Disease Control and Prevention. 2010. Alcohol and other drug use and academic achievement. Accessed February 1, 2016. https://www.cdc.gov/healthyyouth/health_and_academics/pdf/alcohol_other_drug.pdf.
20. Homel, J., K. Thompson & B. Leadbeater. 2014. Trajectories of marijuana use in youth ages 15–25: implications for postsecondary education experiences. J. Stud. Alcohol Drugs 75: 674–683.
21. Fergusson, D.M. & J.M. Boden. 2008. Cannabis use and later life outcomes. Addiction 103: 969–976; discussion 977–978.
22. Ammerman, S., S. Ryan, W.P. Adelman; Committee on Substance Abuse, Committee on Adolescence. 2015. The impact of marijuana policies on youth: clinical, research, and legal update. Pediatrics 135: e769–e785.
23. Sevigny, E.L., R.L. Pacula & P. Heaton. 2014. The effects of medical marijuana laws on potency. Int. J. Drug Policy 25: 308–319.
24. Morris, R.G., M. TenEyck, J.C. Barnes & T.V. Kovandzic. 2014. The effect of medical marijuana laws on crime: evidence from state panel data, 1990–2006. PLoS One 9: e92816.
25. Moore, S.C. 2010. Substitution and complementarity in the face of alcohol-specific policy interventions. Alcohol Alcohol. 45: 403–408.
26. Petry, N.M. 2001. A behavioral economic analysis of polydrug abuse in alcoholics: asymmetrical substitution of alcohol and cocaine. Drug Alcohol Depend. 62: 31–39.
27. Lynne-Landsman, S., M. Livingston & A. Wagenaar. 2013. Effects of state medical marijuana laws on adolescent marijuana use. Am. J. Public Health 103: 1500–1506.
28. Cerdá, M., M. Wall, K.M. Keyes, et al. 2012. Medical marijuana laws in 50 states: investigating the relationship between state legalization of medical marijuana and marijuana use, abuse and dependence. Drug Alcohol Depend. 120: 22–27.
29. Wall, M.M., E. Poh, M. Cerda, et al. 2011. Adolescent marijuana use from 2002 to 2008: higher in states with medical marijuana laws, cause still unclear. Ann. Epidemiol. 21: 714–716.
30. Harper, S., E.C. Strumpf & J.S. Kaufman. 2012. Do medical marijuana laws increase marijuana use? Replication study and extension. Ann. Epidemiol. 22: 207–212.
31. Choo, E.K., M. Benz, N. Zaller, et al. 2014. The impact of state medical marijuana legislation on adolescent marijuana use. J. Adolesc. Health 55: 160–166.
32. Kepple, N.J. & B. Freisthler. 2012. Exploring the ecological association between crime and medical marijuana dispensaries. J. Stud. Alcohol Drugs 73: 523–530.
33. Salomonsen-Sautel, S., S.-J. Min, J.T. Sakai, et al. 2014. Trends in fatal motor vehicle crashes before and after marijuana commercialization in Colorado. Drug Alcohol Depend. 140: 137–144.
34. Anderson, D.M. & D.I. Rees. 2013. Medical marijuana laws, traffic fatalities, and alcohol consumption. J. Law Econ. 56: 333–369.
35. Thies, C.F. & C.A. Register. 1993. Decriminalization of marijuana and the demand for alcohol, marijuana and cocaine. Soc. Sci. J. 30: 385–399.
36. Davis, J.M., B. Mendelson, J.J. Berkes, et al. 2015. Public health effects of medical marijuana legalization in Colorado. Am. J. Prev. Med. 50: 373–379.
37. National Conference of State Legislatures. 2016. State medical marijuana laws. Accessed January 27, 2016. http://www.ncsl.org/research/health/state-medical-marijuana-laws.aspx.
38. Hoffmann, D.E. & E. Weber. 2010. Medical marijuana and the law. N. Engl. J. Med. 362: 1453–1457.
39. Procon.org. 24 Legal medical marijuana states and DC. Accessed April 18, 2016. http://medicalmarijuana.procon.org/view.resource.php?resourceID=000881.
40. Pacula, R.L. & E.L. Sevigny. 2014. Marijuana liberalization policies: why we can't learn much from policy still in motion. J. Policy Anal. Manage. 33: 212–221.
41. Pacula, R.L., D. Powell, P. Heaton & E.L. Sevigny. 2015. Assessing the effects of medical marijuana laws on marijuana use: the devil is in the details. J. Policy Anal. Manage. 34: 7–31.
42. Pertwee, R.G. 2006. Cannabinoid pharmacology: the first 66 years. Br. J. Pharmacol. 147(Suppl. 1): S163–S171.
43. Hillig, K.W. & P.G. Mahlberg. 2004. A chemotaxonomic analysis of cannabinoid variation in Cannabis (Cannabaceae). Am. J. Bot. 91: 966–975.
44. Burgdorf, J.R., B. Kilmer & R.L. Pacula. 2011. Heterogeneity in the composition of marijuana seized in California. Drug Alcohol Depend. 117: 59–61.
45. FDA and Marijuana. 2015. Accessed January 8, 2016. http://www.fda.gov/NewsEvents/PublicHealthFocus/ucm421163.htm.
46. Rigucci, S., T.R. Marques, M. Di Forti, et al. 2016. Effect of high-potency cannabis on corpus callosum microstructure. Psychol. Med. 46: 841–854.
47. Di Forti, M., C. Morgan, P. Dazzan, et al. 2009. High-potency cannabis and the risk of psychosis. Br. J. Psychiatry 195: 488–491.
48. Ramaekers, J.G., G. Kauert, P. van Ruitenbeek, et al. 2006. High-potency marijuana impairs executive function and inhibitory motor control. Neuropsychopharmacology 31: 2296–2303.
49. Li, M.-C., J.E. Brady, C.J. DiMaggio, et al. 2012. Marijuana use and motor vehicle crashes. Epidemiol. Rev. 34: 65–72.
50. Lazar, K. & S. Murphy. 2014. DEA targets doctors linked to medical marijuana. Boston Globe. June 6, 2014.
51. California Medical Association. 2011. Physician recommendation of medical Cannabis guidelines of the Council on Scientific Affairs Subcommittee on Medical Marijuana Practice Advisory. Accessed January 8, 2016. http://www.mbc.ca.gov/Licensees/Prescribing/medical_marijuana_cma-recommend.pdf.
52. Pacula, R.L., R. MacCoun, P. Reuter, et al. 2005. What does it mean to decriminalize marijuana? A cross-national empirical examination. Adv. Health Econ. Health Serv. Res. 16: 347–369.
53. Joffe, A. & W.S. Yancy. 2004. Legalization of marijuana: potential impact on youth. Pediatrics 113: e632–e638.
54. Pacula, R., J. Chriqui & J. King. 2003. Decriminalization in the United States: what does it mean? National Bureau of Economic Research, Cambridge. Working paper No. 9690. Accessed January 8, 2016. http://www.nber.org/papers/w9690.
55. Alexander, M. 2012. The New Jim Crow: Mass Incarceration in the Age of Colorblindess. New York: The New Press.
56. Johnson, B.D., A. Golub, E. Dunlap & S.J. Sifaneck. 2008. An analysis of alternatives to New York city's current marijuana arrest and detention policy. Policing 31: 226–250.
57. Pacula, R.L. & R. Lundberg. 2014. Why changes in price matter when thinking about marijuana policy: a review of the literature on the elasticity of demand. Public Health Rev. 35: 1–18.
58. Washington State Liquor and Cannabis Board. Accessed January 20, 2016. http://www.liq.wa.gov/mj2015/faqs_i-502.
59. Colorado Department of Revenue, Enforcement Division: Marijuana enforcement. Accessed January 20, 2016. https://www.colorado.gov/pacific/enforcement/marijuanaenforcement.
60. Oregon.gov: Recreational Marijuana. Accessed January 20, 2016. http://www.oregon.gov/olcc/marijuana/Pages/default.aspx.
61. Alaska Department of Health and Social Services, Division of Public Health. Know the laws about marijuana. Accessed January 21, 2016. http://dhss.alaska.gov/dph/Director/Pages/marijuana/law.aspx.
62. Oregon.gov. Oregon/Washington/Colorado Comparison. Accessed January 28, 2016. http://www.oregon.gov/olcc/marijuana/Documents/Measure91_sidebysidecomparison.pdf.
63. Carless, W. 2016. Two years later, Uruguay still has no legal marijuana for sale. Global Post. January 9, 2016. Accessed April 18, 2016. http://www.globalpost.com/article/6716408/2016/01/07/uruguay-legal-marijuana-sale.
64. Boidi, M.F., J.M. Cruz, R. Queirolo & E. Bello-Pardo. 2015. Marijuana legalization in Uruguay and beyond. Accessed February 9, 2016. https://www.wilsoncenter.org/sites/default/files/Marijuana%20Legalization%20in%20Uruguay%20and%20Beyond_brief%20report_v3%20(2).pdf.
65. Cher, L. 2016. Uruguay's half-baked marijuana experiment. Foreign Policy. Accessed April 18, 2016. http://foreignpolicy.com/2016/03/21/uruguay-marijuana-legalization.
66. Ferner, M. 2015. Pioneer pot states have collected more than $200 million in marijuana taxes. The Huffington Post. August 2015. Accessed April 18, 2016. http://www.huffingtonpost.com/entry/washington-colorado-marijuana-taxes_us_55d6133be4b07addcb45e65d.
67. Ferner, M. & R.J. Reilly. 2014. Marijuana industry sets its sights on the mainstream. The Huffington Post. November 2014. Accessed April 18, 2016. http://www.huffingtonpost.com/2014/11/24/marijuana-industry-mainstream_n_6195194.html.
68. Sloane, G. 2015. Pot marketers must get creative as digital ad networks just say no. Adweek. Accessed April 18, 2016. http://www.adweek.com/news/technology/pot-marketers-must-get-creative-digital-ad-networks-just-say-no-162682.
69. Jao, C. 2015. How companies are trying to bring marijuana ads online. Entrepreneur. Accessed April 18, 2016. https://www.entrepreneur.com/article/246896.
70. Cabrera-Nguyen, E.P., P. Cavazos-Rehg, M. Krauss, et al. 2016. Young adults’ exposure to alcohol- and marijuana-related content on Twitter. J. Stud. Alcohol Drugs 77: 349–353.
71. Cavazos-Rehg, P., M. Krauss, R. Grucza & L. Bierut. 2014. Characterizing the followers and tweets of a marijuana-focused Twitter handle. J. Med. Internet Res. 16: e157.
72. Emery, S.L., H. Tran, G. Szczypka, et al. 2015. “Check out that #rollgame:” amount and themes of little cigar and cigarillo content on Twitter. In Annual Meeting of the American Public Health Association, Chicago, IL.
73. Cummings, K.M., C.P. Morley, J.K. Horan, et al. 2002. Marketing to America's youth: evidence from corporate documents. Tob. Control 11(Suppl. 1): i5–i17.
74. Pucci, L.G. & M. Siegel. 1999. Features of sales promotion in cigarette magazine advertisements, 1980–1993: an analysis of youth exposure in the United States. Tob. Control 8: 29–36.
75. Distefan, J.M., J.P. Pierce & E.A. Gilpin. 2004. Do favorite movie stars influence adolescent smoking initiation? Am. J. Public Health 94: 1239–1244.
76. Hafez, N. & P.M. Ling. 2006. Finding the Kool Mixx: how Brown & Williamson used music marketing to sell cigarettes. Tob. Control 15: 359–366.
77. Mead, E.L., R.N. Rimal, R. Ferrence & J.E. Cohen. 2014. Understanding the sources of normative influence on behavior: the example of tobacco. Soc. Sci. Med. 115: 139–143.
78. National Center for Chronic Disease Prevention and Health Promotion (US) Office on Smoking and Health. 2012. Preventing tobacco use among youth and young adults: a report of the surgeon general. Atlanta: Centers for Disease Control and Prevention.
79. Sargent, J.D. & R. Hanewinkel. 2015. “Impact of media, movies and TV on tobacco use in the youth.” In The Tobacco Epidemic. Progress in Respiratory Research. 2nd ed. Vol. 42. R. Loddenkemper & M. Kreuter, Eds.: 171–180. Basel: Karger AG.
80. Slater, M.D. & A.F. Hayes. 2010. The influence of youth music television viewership on changes in cigarette use and association with smoking peers: a social identity, reinforcing spirals perspective. Communic. Res. 37: 751–773.
81. de Dios, M.A., B.J. Anderson, D.S. Herman, et al. 2010. Marijuana use subtypes in a community sample of young adult women. Womens Health Issues 20: 201–210.
82. Blanco, C., E. Ogburn, J. Pérez de Los Cobos, et al. 2008. DSM-IV criteria-based clinical subtypes of cannabis use disorders: results from the National Epidemiological Survey on Alcohol and Related Conditions (NESARC). Drug Alcohol Depend. 96: 136–144.
83. Kandel, D.B. & K. Chen. 2000. Types of marijuana users by longitudinal course. J. Stud. Alcohol 61: 367–378.
84. Cohn, A., A. Johnson, S. Ehlke & A.C. Villanti. 2015. Characterizing substance use and mental health profiles of cigar, blunt, and non-blunt marijuana users from the National Survey of Drug Use and Health. Drug Alcohol Depend. 160: 105–111.
85. Mariani, J.J., D. Brooks, M. Haney & F.R. Levin. 2011. Quantification and comparison of marijuana smoking practices: blunts, joints, and pipes. Drug Alcohol Depend. 113: 249–251.
86. Kerr, W.C., T.K. Greenfield, J. Bond, et al. 2007. Age–period–cohort influences on trends in past year marijuana use in the US from the 1984, 1990, 1995 and 2000 National Alcohol Surveys. Drug Alcohol Depend. 86: 132–138.
87. Goncy, E.A. & S. Mrug. 2013. Where and when adolescents use tobacco, alcohol, and marijuana: comparisons by age, gender, and race. J. Stud. Alcohol Drugs 74: 288–300.
88. Gillespie, N.A., M.C. Neale, L.N. Legrand, et al. 2012. Are the symptoms of cannabis use disorder best accounted for by dimensional, categorical, or factor mixture models? A comparison of male and female young adults. Psychol. Addict. Behav. 26: 68–77.
89. Asbridge, M., C. Duff, D.C. Marsh & P.G. Erickson. 2014. Problems with the identification of “problematic” cannabis use: examining the issues of frequency, quantity, and drug use environment. Eur. Addict. Res. 20: 254–267.
90. López-Pelayo, H., A. Batalla, M.M. Balcells, et al. 2015. Assessment of cannabis use disorders: a systematic review of screening and diagnostic instruments. Psychol. Med. 45: 1121–1133.
91. Bashford, J., R. Flett & J. Copeland. 2010. The Cannabis Use Problems Identification Test (CUPIT): development, reliability, concurrent and predictive validity among adolescents and adults. Addiction 105: 615–625.
92. Piontek, D., L. Kraus & D. Klempova. 2008. Short scales to assess cannabis-related problems: a review of psychometric properties. Subst. Abuse Treat. Prev. Policy 3: 25.
93. Annaheim, B., J. Rehm & G. Gmel. 2008. How to screen for problematic cannabis use in population surveys: an evaluation of the Cannabis Use Disorders Identification Test (CUDIT) in a Swiss sample of adolescents and young adults. Eur. Addict. Res. 14: 190–197.
94. van der Pol, P., N. Liebregts, R. de Graaf, et al. 2013. Validation of self-reported cannabis dose and potency: an ecological study. Addiction 108: 1801–1808.
95. Hjorthøj, C.R., A. Fohlmann, A.-M. Larsen, et al. 2012. Correlations and agreement between delta-9-tetrahydrocannabinol (THC) in blood plasma and timeline follow-back (TLFB)-assisted self-reported use of cannabis of patients with cannabis use disorder and psychotic illness attending the CapOpus randomized clin. Addiction 107: 1123–1131.
96. Robinson, S.M., L.C. Sobell, M.B. Sobell & G.I. Leo. 2014. Reliability of the timeline followback for cocaine, cannabis, and cigarette use. Psychol. Addict. Behav. 28: 154–162.
97. Van der Linden, T., P. Silverans & A.G. Verstraete. 2014. Comparison between self-report of cannabis use and toxicological detection of THC/THCCOOH in blood and THC in oral fluid in drivers in a roadside survey. Drug Test. Anal. 6: 137–142.
98. Delforterie, M., H. Creemers, A. Agrawal, et al. 2015. Functioning of cannabis abuse and dependence criteria across two different countries: the United States and the Netherlands. Subst. Use Misuse 50: 242–250.
99. Kelly, E. & I. Rasul. 2014. Policing cannabis and drug related hospital admissions: evidence from administrative records. J. Public Econ. 112: 89–114.
100. Morris, R.G., M. TenEyck, J.C. Barnes & T.V. Kovandzic. 2014. The effect of medical marijuana laws on crime: evidence from state panel data, 1990–2006. PLoS One 9: e92816.
101. Shanahan, M. & A. Ritter. 2014. Cost benefit analysis of two policy options for cannabis: status quo and legalisation. PLoS One 9: e95569.
102. Blumenauer, E. & J. Polis. 2012. The path forward: rethinking federal marijuana policy. Accessed February 8, 2016. http://polis.house.gov/uploadedfiles/the_path_forward.pdf.
103. State of Washington. 2011. Initiative measure No. 502. An act relating to marijuana. Accessed January 10, 2016. http://sos.wa.gov/_assets/elections/initiatives/i502.pdf.
104. State of Colorado. Proposition BB: retain revenue in excess of blue book estimate. Accessed February 9, 2016. http://www.leg.state.co.us/LCS/InitiativeReferendum/1516initrefr.nsf/b74b3fc5d676cdc987257ad8005bce6a/f4d9ff58ad46b25687257e310079be83/$FILE/FinalDraftPacketPropositionBB.pdf.
105. Williams, J., R. Liccardo Pacula, et al. 2004. Alcohol and marijuana use among college students: economic complements or substitutes? Health Econ. 13: 825–843.
106. DiNardo, J. & T. Lemieux. 2001. Alcohol, marijuana, and American youth: the unintended consequences of government regulation. J. Health Econ. 20: 991–1010.
107. Pacula, R.L. 1998. Does increasing the beer tax reduce marijuana consumption? J. Health Econ. 17: 557–585.
108. Bachhuber, M.A., B. Saloner, C.O. Cunningham & C.L. Barry. 2014. Medical cannabis laws and opioid analgesic overdose mortality in the United States, 1999–2010. JAMA Intern. Med. 174: 1668–1673.
109. Chaloupka, F.J., R.L. Pacula, M.C. Farrelly, et al. 1999. Do higher cigarette prices encourage youth to use marijuana? Accessed April 18, 2016. http://www.nber.org/papers/w6939.pdf.
110. Farrelly, M.C., J.W. Bray, G.A. Zarkin & B.W. Wendling. 2001. The joint demand for cigarettes and marijuana: evidence from the National Household Surveys on Drug Abuse. J. Health Econ. 20: 51–68.
111. Kandel, D. 1975. Stages in adolescent involvement in drug use. Science 190: 912–914.
112. Timberlake, D.S., B.C. Haberstick, C.J. Hopfer, et al. 2007. Progression from marijuana use to daily smoking and nicotine dependence in a national sample of U.S. adolescents. Drug Alcohol Depend. 88: 272–281.
113. Patton, G.C., C. Coffey, J.B. Carlin, et al. 2005. Reverse gateways? Frequent cannabis use as a predictor of tobacco initiation and nicotine dependence. Addiction 100: 1518–1525.
114. Okoli, C.T.C., C.G. Richardson, P.A. Ratner & J.L. Johnson. 2008. Adolescents’ self-defined tobacco use status, marijuana use, and tobacco dependence. Addict. Behav. 33: 1491–1499.
115. Ford, D.E., H.T. Vu & J.C. Anthony. 2002. Marijuana use and cessation of tobacco smoking in adults from a community sample. Drug Alcohol Depend. 67: 243–248.
116. Sifaneck, S.J., B.D. Johnson & E. Dunlap. 2005. Cigars-for-blunts: choice of tobacco products by blunt smokers. J. Ethn. Subst. Abuse 4: 23–42.
117. Penfold, R.B. & F. Zhang. 2013. Use of interrupted time series analysis in evaluating health care quality improvements. Acad. Pediatr. 13(Suppl. 6): S38–S44.
118. Ramsay, C.R., L. Matowe, R. Grilli, et al. 2003. Interrupted time series designs in health technology assessment: lessons from two systematic reviews of behavior change strategies. Int. J. Technol. Assess. Health Care 19: 613–623.
119. Ross, H.L., D.T. Campbell & G.V. Glass. 1970. Determining the social effects of a legal reform: the British “breathalyser” crackdown of 1967. Am. Behav. Sci. 13: 493–509.
120. Somers, M.-A., P. Zhu, R.T. Jacob & H. Bloom 2013. The validity and precision of the comparative interrupted time series design and the difference-in-difference design in educational evaluation. MDRC working paper in research methodology. MDRC, New York.
121. Hasin, D.S., C.P. O'Brien, M. Auriacombe, et al. 2013. DSM-5 criteria for substance use disorders: recommendations and rationale. Am. J. Psychiatry 170: 834–851.
122. Colorado Official State Web Portal. Accessed August 2, 2016. https://www.colorado.gov/pacific/marijuana/laws-about-marijuana-use.
123. Colorado Official State Web Portal. Accessed August 2, 2016. https://www.colorado.gov/pacific/enforcement/business-license-applicants-retail-marijuana-2.
124. Washington State Liquor and Cannabis Board. Fact Sheet. Accessed August 2, 2016. http://www.liq.wa.gov/mj2015/fact-sheet.
125. Washington State Liquor and Cannabis Board. Frequently Asked Questions about Implementing Initiative 502. Accessed August 2, 2016. http://www.liq.wa.gov/mj2015/faqs_i-502#Retail-Stores.
126. Washington Administrative Code. Title 314 Chapter 55 Section 15. General information about marijuana licenses. Accessed August 2, 2016. http://apps.leg.wa.gov/wac/default.aspx?cite=314-55&full=true#314-55-015.
127. What's Legal Oregon. Accessed August 2, 2016. http://whatslegaloregon.com.
128. Oregon Liquor Control Commission. Frequently Asked Questions – Taxes.” Accessed August 2, 2016. http://www.oregon.gov/olcc/marijuana/Pages/Frequently-Asked-Questions.aspx#Taxes.
129. Oregon Liquor Control Commission. Frequently Asked Questions – Licensing – General. Accessed August 2, 2016. http://www.oregon.gov/olcc/marijuana/Pages/Frequently-Asked-Questions.aspx#Licensing_-_General.
130. Alaska Alcohol and Marijuana Control Office. Marijuana Licensing Frequently Asked Questions. Accessed August 2, 2016. https://www.commerce.alaska.gov/web/amco/MarijuanaLicensingFAQs.aspx.
131. AK Stat § 43.61.010. 2014. Excise Tax on Marijuana. Accessed August 2, 2016. https://www.commerce.alaska.gov/web/portals/9/pub/MCB/StatutesAndRegulations/MJ_BallotMeasure2.pdf.
132. Dimick J.B. & A.M. Ryan. 2014. Methods for Evaluating Changes in Health Care Policy. JAMA. 312: 2401.
133. Besley, T. & A. Case. 2000. Unnatural experiments? Estimating the incidence of endogenous policies. Econ. J. 110: F672–F694.
134. Han X., K.R. Yabroff, A.S. Robbins, et al. 2014. Dependent Coverage and Use of Preventive Care under the Affordable Care Act. N. Eng.l J. Med. 371: 2341–2342.